Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older (children under 18 are not eligible due to how rare this disease is in that age group)
- People who have been diagnosed with prostate cancer (either localised or spread to other parts of the body), confirmed through a tissue sample
- People who have been receiving hormone therapy to lower androgen levels (such as LHRH agonists/antagonists or androgen receptor blockers) for at least one month, with a plan to continue for at least four more months at the time of joining
- People who self-identify as Black
- People who have been cleared by their doctor or a qualified clinical exercise specialist to take part in physical exercise
- People who do not have medical conditions that could worsen with exercise, such as bone disease at high risk of fracture (not counting bone metastases) or uncontrolled heart, lung, or metabolic conditions
- People who currently do 60 minutes or less of moderate to vigorous structured exercise per week
- People who speak English and/or Spanish, and are able to communicate and complete written forms in one of those languages
- People who are willing and able to travel to Dana-Farber Cancer Institute (DFCI) for the required data collection visits
Who may not be able to join:
- People who are not currently receiving hormone therapy targeting androgen levels (such as LHRH agonists/antagonists or androgen receptor blockers)
- People with uncontrolled heart, lung, or metabolic conditions that could get worse with exercise
- People who do not speak English or Spanish
- People who have a second cancer diagnosis, with the exception of basal cell carcinoma (a common, less serious form of skin cancer)
- People who already do more than 60 minutes of moderate to vigorous structured exercise per week
- People who are unable to travel to DFCI for the necessary data collection visits
- People who, in the opinion of the study investigators, may not be able to safely follow the study's monitoring requirements (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Christina C Dieli-Conwright, PhD, MPH, Dana-Farber Cancer Institute
Phone: 617-632-3800
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cardiovascular disease risk factors
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.